GxP Lifeline
Not-To-Be Missed Blog Posts From 2021
In 2021, GxP Lifeline featured informative content with exceptional thought leadership and insights into the industry. As the final blog post of the year, we’re offering a compilation of posts from 2021 that you don’t want to miss – they’ll help you tackle some of the challenges you’ll be facing next year.
The FDA Just Called! Are You Ready for an Inspection?
When the U.S. Food and Drug Administration (FDA) gives you a ring, and explains they’ll be dropping by to perform an inspection, some people go into panic mode. Make your life easier by ensuring you’re always ready for an audit. Get tips that explain how.
5 Medical Device Best Practices for Managing Risk to Users, Patients, and the Environment
By implementing a risk-based approach, medical device companies can reduce some of their most pressing concerns related to speed to market, regulatory compliance, and more.
3 Practical Ways to Prepare for Pharma’s AI-Driven Future
Every year, artificial intelligence (AI) picks up more speed, and the advantages to be gained from emerging technologies are enormous. AI is not only one of the most sophisticated forms of technology out there, it’s also one of the most complicated, so knowing where to begin is a challenge. Learn practical steps you can take today to prepare for tomorrow.
5 Steps to Metrics Collection and Usage
Organizations in the life sciences industry are swimming in quality and manufacturing data. Before diving in head first, take a step back and consider what you want to learn from the data you have collected. To be effective in your efforts, follow these five basic steps.
Overview of the Medical Device Design History File, Technical File, and Design Dossier
Medical device manufacturers have to meet strict regulatory requirements, which includes 21 CFR 820.30. Understand how this guidance relates to design controls and ensures medical device manufacturers produce safe, effective, compliant products.
Last but certainly not least, don’t miss the insights from our leadership team. These were all included in our last newsletter of the year, but just in case you’re not on the mailing list, don’t miss the opportunity to learn from some of the best minds at MasterControl:
- Rapid Acceleration in Technology for Life Sciences Quality and Manufacturing by Jon Beckstrand, CEO
- Insights Into APAC and Modern Manufacturing by Sara Bresee, Managing Director of APAC
- The Future of Responsible AI in Life Sciences by Rajesh Talpade, Senior VP of Product
- How to Not Fail an Inspection by Matt M. Lowe, Chief Product and Marketing Officer
- How Electronic Batch Records and Device History Records Close the Digital Manufacturing Gap by Brain Curran, Senior VP of Strategic Growth
Next year, we will have more insights for you. Until then, please enjoy these outstanding posts from 2021.
Dale Thompson is a content marketing specialist at MasterControl’s headquarters in Salt Lake City, Utah. Her areas of expertise are pharmaceuticals and manufacturing. Thompson’s varied career includes extensive work in grant writing and journalism as well as crafting content to highlight the work of biology professors and paleontologists. She has a bachelor’s degree from Evergreen State College and a master’s degree in professional communication from Westminster College.
Free Resource
Enjoying this blog? Learn More.
Most Common Reasons for FDA Form 483 Observations and Warning Letters in Medical Device Environments
Download Now